24-dehydrocholesterol reductase (DHCR24) mRNA (DHCR24 mRNA)

24-dehydrocholesterol reductase (DHCR24) mRNA encodes a critical enzyme in the Bloch pathway of cholesterol biosynthesis, responsible for converting desmosterol into cholesterol [UniProt, 2024]. Also known as Seladin-1, this target is highly expressed in the brain and plays a vital role in neuroprotection by regulating lipid raft formation and inhibiting apoptotic pathways [Greeve et al., 2000]. In Alzheimer's disease, DHCR24 mRNA expression is significantly downregulated, contributing to increased neuronal vulnerability to oxidative stress [Wikipedia, 2024]. Conversely, the mRNA is often overexpressed in various cancers and is a necessary host factor for the replication of the Hepatitis C virus (HCV), making it a target for therapeutic downregulation [Saitoh et al., 2009]. Experimental strategies targeting DHCR24 mRNA utilize siRNAs or antisense oligonucleotides to reduce enzyme levels, which has shown efficacy in inhibiting HCV replication and suppressing certain tumor types [PubMed, 2024]. However, therapeutic modulation of this target must be carefully managed due to the risk of desmosterol accumulation, which can lead to systemic toxicity and developmental issues similar to those seen in the genetic disorder desmosterolosis [Waterham et al., 2001].

Other names

Seladin-1 mRNASELADIN1 mRNADesmosterol-delta-24-reductase mRNA3-beta-hydroxysterol-delta-24-reductase mRNADHCR24 transcript

RNA interference (RNAi) or antisense-mediated degradation of the mRNA transcript to prevent translation of the 24-dehydrocholesterol reductase enzyme [Saitoh et al., 2009].